ESPR ev to operating cash flow history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc EV to Operating Cash Flow — Quarterly
Period ending	EV to Operating Cash Flow
Mar 31, 2026	-38.8268×
Dec 31, 2025	27.7584×
Sep 30, 2025	-241.1678×
Jun 30, 2025	-22.4647×
Mar 31, 2025	-20.5752×
Dec 31, 2024	-16.6825×
Sep 30, 2024	-12.6222×
Jun 30, 2024	-72.3954×
Mar 31, 2024	14.7599×
Dec 31, 2023	-21.4482×
Sep 30, 2023	-15.3141×
Jun 30, 2023	-12.0926×
Mar 31, 2023	-4.4376×
Dec 31, 2022	-14.0582×
Sep 30, 2022	-13.3505×
Jun 30, 2022	-16.1345×
Mar 31, 2022	-16.9136×
Dec 31, 2021	-4.0816×
Sep 30, 2021	-10.6826×
Jun 30, 2021	-13.0428×
Mar 31, 2021	-10.8753×
Dec 31, 2020	-8.4522×
Sep 30, 2020	-11.4988×
Jun 30, 2020	9.2799×
Mar 31, 2020	-10.4392×
Dec 31, 2019	-29.3549×
Sep 30, 2019	-13.5316×
Jun 30, 2019	-17.698×
Mar 31, 2019	9.8696×
Dec 31, 2018	-41.7075×
Sep 30, 2018	-31.6502×
Jun 30, 2018	-26.1192×
Mar 31, 2018	-43.8244×
Dec 31, 2017	-48.5479×
Sep 30, 2017	-33.4122×
Jun 30, 2017	-39.1588×
Mar 31, 2017	-22.7054×
Dec 31, 2016	-15.1353×
Sep 30, 2016	-18.7581×
Jun 30, 2016	-24.2875×
Mar 31, 2016	-35.4709×
Dec 31, 2015	-50.6738×
Sep 30, 2015	-38.417×
Jun 30, 2015	-198.7306×
Mar 31, 2015	-183.8295×
Dec 31, 2014	-85.2152×
Sep 30, 2014	-39.6454×
Jun 30, 2014	-33.0534×
Mar 31, 2014	-20.1826×
Dec 31, 2013	-20.473×
Sep 30, 2013	-45.1735×
Jun 30, 2013	-59.0113×
Mar 31, 2013	-72.5333×
Dec 31, 2012	-65.6406×
Sep 30, 2012	0×
Jun 30, 2012	0×
Mar 31, 2012	0×
Sep 30, 2003	-1.6244×
Jun 30, 2003	-6.8949×
Mar 31, 2003	-5.4789×
Dec 31, 2002	-5.172×
Sep 30, 2002	-4.1224×
Jun 30, 2002	-3.3397×
Mar 31, 2002	-0.643×
Dec 31, 2001	0.9044×
Sep 30, 2001	2.3186×
Jun 30, 2001	-1.0921×
Mar 31, 2001	1.2238×
Dec 31, 2000	6.279×
Sep 30, 2000	12.6986×
Jun 30, 2000	3.4739×
Mar 31, 2000	-2.2483×